By contrast, ARHGAP24 (FilGAP) emerged as a tumor-suppressor in renal cell carcinoma by inhibiting G1/S phase cell cycle progression, increasing apoptosis, and inhibited tumor growth32. Here, ARHGAP24 is linked to neoplasm.